Host: Peter Buch, MD, FACG, AGAF, FACP     Guest: Douglas Drossman, MD  We all face angry and disruptive patients from time to time, making it essential to know how to properly de-escalate and handle the situation. That’s why Dr. Peter Buch speaks with Dr. Douglas Drossman, co-author of an article that was published in the American Journal of Gastroenterology titled “De-escalate, Don’t Escalate: Essential Steps to Effectively Recognize and Manage the Patient Who Is Angry and Disruptive.”

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Douglas Drossman, MD We all face angry and disruptive patients from time to time, making it essential to know how to properly de-escalate and handle the situation. That’s why Dr. Peter Buch speaks with Dr. Douglas Drossman, co-author of an article that was published in the American Journal of Gastroenterology titled “De-escalate, Don’t Escalate: Essential Steps to Effectively Recognize and Manage the Patient Who Is Angry and Disruptive.”

How to Recognize & Manage an Angry Patient


Host: Peter Buch, MD, FACG, AGAF, FACP     Guest: Siddharth Singh, MD  How can we use biomarkers to treat patients with ulcerative colitis? That’s the exact question the latest guideline from the American Gastroenterological Association (AGA) sought to address. Learn about this guideline and other best practices with Dr. Peter Buch and Dr. Siddharth Singh, Assistant Professor of Medicine at the University of California-San Diego and co-author of an article published in Gastroenterology in March 2023 titled “AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis.”

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Siddharth Singh, MD How can we use biomarkers to treat patients with ulcerative colitis? That’s the exact question the latest guideline from the American Gastroenterological Association (AGA) sought to address. Learn about this guideline and other best practices with Dr. Peter Buch and Dr. Siddharth Singh, Assistant Professor of Medicine at the University of California-San Diego and co-author of an article published in Gastroenterology in March 2023 titled “AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis.”

Biomarkers for Ulcerative Colitis Management: A Review of the AGA Guidelines


Host: Peter Buch, MD, FACG, AGAF, FACP     Guest: Alan Bonder, MD  According to the United Network for Organ Sharing (UNOS), more than 95 percent of patients are alive and doing well after a liver transplant. So what else can we learn from UNOS? Join Dr. Peter Buch as he speaks with Dr. Alan Bonder, Assistant Professor of Medicine at Harvard Medical School. 

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alan Bonder, MD According to the United Network for Organ Sharing (UNOS), more than 95 percent of patients are alive and doing well after a liver transplant. So what else can we learn from UNOS? Join Dr. Peter Buch as he speaks with Dr. Alan Bonder, Assistant Professor of Medicine at Harvard Medical School.

A Look into Liver Transplants


Host: Peter Buch, MD, FACG, AGAF, FACP     Guest: Kunal Jajoo, MD  The American Gastroenterological Association (AGA) recently published updated clinical guidelines for the use of endoscopic ultrasound (EUS). Are there caveats involved with these recommendations? Join Dr. Peter Buch as he speaks with Dr. Kunal Jajoo, Assistant Professor of Medicine at Harvard Medical School, about the best utilization of EUS in clinical practice.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Kunal Jajoo, MD The American Gastroenterological Association (AGA) recently published updated clinical guidelines for the use of endoscopic ultrasound (EUS). Are there caveats involved with these recommendations? Join Dr. Peter Buch as he speaks with Dr. Kunal Jajoo, Assistant Professor of Medicine at Harvard Medical School, about the best utilization of EUS in clinical practice.

Reviewing Best Practices for Endoscopic Ultrasound


Host: Charles Turck, PharmD, BCPS, BCCCP     Guest: Suijit Janardhan, MD, PhD  Diabetic patients have a significant risk for developing more advanced liver disease, and the disease that they’re particularly at risk for is steatotic liver disease. Dive into this episode to learn more with Dr. Charles Turck and Dr. Sujit Janardhan, Assistant Professor in the Department of Internal Medicine, Division of Digestive Diseases and Nutrition, and the Department of Transplant Surgery at Rush University Medical Center in Chicago.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Suijit Janardhan, MD, PhD Diabetic patients have a significant risk for developing more advanced liver disease, and the disease that they’re particularly at risk for is steatotic liver disease. Dive into this episode to learn more with Dr. Charles Turck and Dr. Sujit Janardhan, Assistant Professor in the Department of Internal Medicine, Division of Digestive Diseases and Nutrition, and the Department of Transplant Surgery at Rush University Medical Center in Chicago.

Disease Spotlight: Reflecting on Liver Health in Diabetes Care


Host: Peter Buch, MD, FACG, AGAF, FACP     Guest: Herbert L. Bonkovsky, MD  If an elevation of delta aminolevulinic or porphobilinogen occurs in the urine more than three times what is normal, that is presumptive acute hepatic porphyria (AHP. Join the conversation as Dr. Peter Buch speaks with Dr. Herbert Bonkovsky, Professor of Medicine and Molecular Medicine and Translational Science at Wake Forest University, about his article published in Gastroenterology.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Herbert L. Bonkovsky, MD If an elevation of delta aminolevulinic or porphobilinogen occurs in the urine more than three times what is normal, that is presumptive acute hepatic porphyria (AHP. Join the conversation as Dr. Peter Buch speaks with Dr. Herbert Bonkovsky, Professor of Medicine and Molecular Medicine and Translational Science at Wake Forest University, about his article published in Gastroenterology.

Updates on the Diagnosis & Management of AHP


Host: Peter Buch, MD, FACG, AGAF, FACP     Guest: Sidney Barritt, MD  Even though nonalcoholic fatty liver disease is the most common form of chronic liver disease in the United States, there are unfortunately no FDA-approved medications for this condition. That’s why Dr. Peter Buch speaks with Dr. Sidney Barritt about top treatment strategies for nonalcoholic fatty liver disease in part one of this two-episode series. Dr. Barritt is an Associate Professor of Medicine and the Director of Hepatology at the UNC Liver Center at the University of North Carolina.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Sidney Barritt, MD Even though nonalcoholic fatty liver disease is the most common form of chronic liver disease in the United States, there are unfortunately no FDA-approved medications for this condition. That’s why Dr. Peter Buch speaks with Dr. Sidney Barritt about top treatment strategies for nonalcoholic fatty liver disease in part one of this two-episode series. Dr. Barritt is an Associate Professor of Medicine and the Director of Hepatology at the UNC Liver Center at the University of North Carolina.

Treatment Strategies for Nonalcoholic Fatty Liver Disease: Part 1


Host: Peter Buch, MD, FACG, AGAF, FACP     Guest: Sidney Barritt, MD  Even though nonalcoholic fatty liver disease is the most common form of chronic liver disease in the United States, there are unfortunately no FDA-approved medications for this condition. That’s why Dr. Peter Buch speaks with Dr. Sidney Barritt about even more treatment strategies for nonalcoholic fatty liver disease in the second and final part of this two-episode series. Dr. Barritt is an Associate Professor of Medicine and the Director of Hepatology at the UNC Liver Center at the University of North Carolina.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Sidney Barritt, MD Even though nonalcoholic fatty liver disease is the most common form of chronic liver disease in the United States, there are unfortunately no FDA-approved medications for this condition. That’s why Dr. Peter Buch speaks with Dr. Sidney Barritt about even more treatment strategies for nonalcoholic fatty liver disease in the second and final part of this two-episode series. Dr. Barritt is an Associate Professor of Medicine and the Director of Hepatology at the UNC Liver Center at the University of North Carolina.

Treatment Strategies for Nonalcoholic Fatty Liver Disease: Part 2


Host: Peter Buch, MD, FACG, AGAF, FACP     Guest: Marianna Arvanitakis, MD, PhD  Consuming ultra-processed foods can pose many risks to your health that go beyond the GI system. Explore the risks associated with ultra-processed foods with Dr. Peter Buch and Dr. Marianna Arvanitakis, Associate Clinical Professor in the Department of Gastroenterology, Hepatopancreatology, and Digestive Oncology from the HUB Erasme Hospital in Brussels, Belgium. 

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Marianna Arvanitakis, MD, PhD Consuming ultra-processed foods can pose many risks to your health that go beyond the GI system. Explore the risks associated with ultra-processed foods with Dr. Peter Buch and Dr. Marianna Arvanitakis, Associate Clinical Professor in the Department of Gastroenterology, Hepatopancreatology, and Digestive Oncology from the HUB Erasme Hospital in Brussels, Belgium.

Ultra-Processed Food Consumption: What Are the Risks?


Host: Peter Buch, MD, FACG, AGAF, FACP     Guest: Claire Jansson-Knodell, MD  When a person has a low IgA level, the tissue transglutaminase immunoglobulin A antibody is no longer a useful screening test for celiac disease. So how should we be assessing patients with an IgA deficiency? To discuss these new recommendations, Dr. Peter Buch is joined by Dr. Claire Jansson-Knodell, Gastroenterologist at the Cleveland Clinic’s Digestive Disease Institute.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Claire Jansson-Knodell, MD When a person has a low IgA level, the tissue transglutaminase immunoglobulin A antibody is no longer a useful screening test for celiac disease. So how should we be assessing patients with an IgA deficiency? To discuss these new recommendations, Dr. Peter Buch is joined by Dr. Claire Jansson-Knodell, Gastroenterologist at the Cleveland Clinic’s Digestive Disease Institute.

Diagnosing & Managing Celiac Disease: Reviewing Updated Recommendations


Looking to digest the latest in gastroenterology? GI Insights is here to provide updates on screening guidelines, diagnostic options, and management tools for all diseases and disorders affecting the gastrointestinal tract.

GI Insights

Guest: Jack Grider, PhD     Host: Mark DeLegge, MD  What is the underlying mechanism of propulsion in the digestive system, and how is motility stimulated? How are some newer pharmacotherapies looking to target serotonin to treat conditions such as IBS and constipation? Dr. Jack Grider, professor in the department of medicine, division of gastroenterology at the Virginia Commonwealth University School of Medicine, talks about future pharmacotherapy directions that either suppress or encourage motility in the digestive system. Hosted by Dr. Mark DeLegge.

Guest: Jack Grider, PhD Host: Mark DeLegge, MD What is the underlying mechanism of propulsion in the digestive system, and how is motility stimulated? How are some newer pharmacotherapies looking to target serotonin to treat conditions such as IBS and constipation? Dr. Jack Grider, professor in the department of medicine, division of gastroenterology at the Virginia Commonwealth University School of Medicine, talks about future pharmacotherapy directions that either suppress or encourage motility in the digestive system. Hosted by Dr. Mark DeLegge.

The Motility of the Gut: What Do We Know?


Host: Mark DeLegge, MD     Guest: William J. Sandborn, MD  The current treatment paradigm for Crohn's disease is a pyramid approach, where patients are given the safest medications before pursuing more aggressive strategies. New evidence suggests that Crohn's disease should be treated with the most effective medications first, such as anti-TNF therapies. But is a top-down strategy safe enough for most patients? Dr. William Sandborn, professor of medicine and gastrointestinal research at Mayo Clinic College of Medicine, describes the results of new Crohn's disease trials and research. Is using steroids to treat Crohn's disease an idea of the past, or are steroids still effective for certain patients? Dr. Mark DeLegge hosts.

Host: Mark DeLegge, MD Guest: William J. Sandborn, MD The current treatment paradigm for Crohn's disease is a pyramid approach, where patients are given the safest medications before pursuing more aggressive strategies. New evidence suggests that Crohn's disease should be treated with the most effective medications first, such as anti-TNF therapies. But is a top-down strategy safe enough for most patients? Dr. William Sandborn, professor of medicine and gastrointestinal research at Mayo Clinic College of Medicine, describes the results of new Crohn's disease trials and research. Is using steroids to treat Crohn's disease an idea of the past, or are steroids still effective for certain patients? Dr. Mark DeLegge hosts.

Shifts in Crohn's Disease Treatment Models


Host: Jay Goldstein, MD     Guest: Douglas Drossman, MD  Host Dr. Jay Goldstein discusses the latest in IBS &amp; Functional GI Disorders (FGIDs) with guest expert Dr. Douglas Drossman of the Drossman Center for the Education and Practice of Integrated Care. Dr. Drossman is Professor Emeritus in the departments of Gastroenterology and Psychiatry at the Center for Functional GI and Motility, University of North Carolina at Chapel Hill.

Host: Jay Goldstein, MD Guest: Douglas Drossman, MD Host Dr. Jay Goldstein discusses the latest in IBS &amp; Functional GI Disorders (FGIDs) with guest expert Dr. Douglas Drossman of the Drossman Center for the Education and Practice of Integrated Care. Dr. Drossman is Professor Emeritus in the departments of Gastroenterology and Psychiatry at the Center for Functional GI and Motility, University of North Carolina at Chapel Hill.

IBS and Functional GI Disorders (FGIDs)


Guest: Michael Vaezi, MD, PhD     Host: Mark DeLegge, MD  Gastroesophageal reflux disease (GERD) is the most common GI diagnosis. But many aspects of diagnosing and treating GERD and related syndromes vary considerably. Now, the AGA has issued new evidence-based guidelines on this widespread disorder. Some of the recommendations may surprise you. Dr. Michael Vaezi, co-author of the guidelines, discusses the best GERD management strategies with host Dr. Mark DeLegge. To view the AGA's GERD Guidelines, please click here.

Guest: Michael Vaezi, MD, PhD Host: Mark DeLegge, MD Gastroesophageal reflux disease (GERD) is the most common GI diagnosis. But many aspects of diagnosing and treating GERD and related syndromes vary considerably. Now, the AGA has issued new evidence-based guidelines on this widespread disorder. Some of the recommendations may surprise you. Dr. Michael Vaezi, co-author of the guidelines, discusses the best GERD management strategies with host Dr. Mark DeLegge. To view the AGA's GERD Guidelines, please <a href="/media/images/cmsimages/GERD_Guidelines,_AGA.pdf" rel="nofollow" target="_blank">click here</a>.

The New GERD Guidelines


Guest: Sheila Crowe, MD     Host: Jay Goldstein, MD  Food allergies are becoming increasingly common. Such allergies are often not easy to diagnose, and can present differently in adults and children. What is the difference between a food allergy and a specific food intolerance? What causes food allergies, and are there effective treatments beyond avoidance? Host Dr. Jay Goldstein probes the truth about food allergies with Dr. Sheila Crowe, professor of medicine in the division of gastroenterology and hepatology at the University of Virginia.

Guest: Sheila Crowe, MD Host: Jay Goldstein, MD Food allergies are becoming increasingly common. Such allergies are often not easy to diagnose, and can present differently in adults and children. What is the difference between a food allergy and a specific food intolerance? What causes food allergies, and are there effective treatments beyond avoidance? Host Dr. Jay Goldstein probes the truth about food allergies with Dr. Sheila Crowe, professor of medicine in the division of gastroenterology and hepatology at the University of Virginia.

Food Allergies: Fact from Fiction


Host Dr. Jay Goldstein welcomes Dr. Sunanda V. Kane, Professor of Medicine in the Department of Gastroenterology &amp; Hepatology at Mayo Clinic, to dicuss the latest in Crohn's disease diagnosis and management. Dr. Kane is author of IBD Self-Management: The AGA Guide to Crohn's Disease and Ulcerative Colitis, now in its second edition.

Host Dr. Jay Goldstein welcomes Dr. Sunanda V. Kane, Professor of Medicine in the Department of Gastroenterology &amp; Hepatology at Mayo Clinic, to dicuss the latest in Crohn's disease diagnosis and management. Dr. Kane is author of IBD Self-Management: The AGA Guide to Crohn's Disease and Ulcerative Colitis, now in its second edition.

Crohn's Disease: Latest Diagnosis, Treatment & Management Strategies


Guest: Thomas D. Wang, MD, PhD     Host: Mark DeLegge, MD  Microscopic imaging of the digestive tract moves beyond examination of tissue at subcellular levels, helping us identify molecular regions in which to probe for dysplasia. Dr. Thomas Wang, assistant professor of medicine and biomedical engineering at the University of Michigan Medical School, details this 'biopsy inside the body' with host Dr. Mark DeLegge. How could this technology shape the future of GI practice? How does this differ from chromoendoscopy, autofluorescence, and other current technologies?

Guest: Thomas D. Wang, MD, PhD Host: Mark DeLegge, MD Microscopic imaging of the digestive tract moves beyond examination of tissue at subcellular levels, helping us identify molecular regions in which to probe for dysplasia. Dr. Thomas Wang, assistant professor of medicine and biomedical engineering at the University of Michigan Medical School, details this 'biopsy inside the body' with host Dr. Mark DeLegge. How could this technology shape the future of GI practice? How does this differ from chromoendoscopy, autofluorescence, and other current technologies?

Endoscopic Imaging Optics for Assessing Dysplasia


Host: Jay Goldstein, MD     Guest: Richard Fedorak, MD  Steroids used to be the standard treatment for inflammatory bowel disease. But now biologic and immunosuppresive therapies are often used. How can we increase the efficacy of these medications? What combinations work best? Dr. Richard Fedorak, professor of medicine in the division of gastroenterology at the University of Alberta in Canada, discusses IBD treatments with host Dr. Jay Goldstein.

Host: Jay Goldstein, MD Guest: Richard Fedorak, MD Steroids used to be the standard treatment for inflammatory bowel disease. But now biologic and immunosuppresive therapies are often used. How can we increase the efficacy of these medications? What combinations work best? Dr. Richard Fedorak, professor of medicine in the division of gastroenterology at the University of Alberta in Canada, discusses IBD treatments with host Dr. Jay Goldstein.

Evolving Treatment of Inflammatory Bowel Disease


Guest: Brian Lacy, MD, PhD     Host: Lee Freedman, MD  Resistance to proton pump inhibitors, or PPIs, is not uncommon among patients with gastroesophogeal reflux disease, or GERD. How should physicians initially approach managing patients with suspected GERD, and at what point should physicians classify a patient as a PPI non-responder? Our guest, Dr. Brian Lacy, associate professor of medicine at Dartmouth Medical School, and director of the GI Motility Laboratory at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, suggests tests that physicians might use in evaluating patients with refractory GERD, including upper endoscopy and various types of pH monitoring. What therapeutic strategies can physicians use to manage these patients? Hosted by Dr. Freedman.

Guest: Brian Lacy, MD, PhD Host: Lee Freedman, MD Resistance to proton pump inhibitors, or PPIs, is not uncommon among patients with gastroesophogeal reflux disease, or GERD. How should physicians initially approach managing patients with suspected GERD, and at what point should physicians classify a patient as a PPI non-responder? Our guest, Dr. Brian Lacy, associate professor of medicine at Dartmouth Medical School, and director of the GI Motility Laboratory at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, suggests tests that physicians might use in evaluating patients with refractory GERD, including upper endoscopy and various types of pH monitoring. What therapeutic strategies can physicians use to manage these patients? Hosted by Dr. Freedman.

When PPIs Fail: Evaluating and Managing Patients with Refractory GERD


Guest: Richard Fedorak, MD     Host: Jay Goldstein, MD  What are probiotics, and how do strains differ? How can they be used most effectively? Dr. Richard Fedorak, professor of medicine in the division of gastroenterology at the University of Alberta in Canada, probes the potential of probiotics with host Dr. Jay Goldstein. Can they be used to replace medications for certain patients with gastrointestinal disorders? Find out what you should you tell your patients about probiotics.

Guest: Richard Fedorak, MD Host: Jay Goldstein, MD What are probiotics, and how do strains differ? How can they be used most effectively? Dr. Richard Fedorak, professor of medicine in the division of gastroenterology at the University of Alberta in Canada, probes the potential of probiotics with host Dr. Jay Goldstein. Can they be used to replace medications for certain patients with gastrointestinal disorders? Find out what you should you tell your patients about probiotics.

What GI Physicians Need to Know About Probiotics


Guest: Mary Igo, MBA, RN     Host: Mark DeLegge, MD  The Physician Quality Reporting Initiative (PQRI) is a CMS-based program designed to help medical professionals measure performance outcomes in their practice. How does the PQRI define quality, and how can it provide more concrete measurements of quality? What do GI practices need to know when becoming involved in the PQRI? Mary Igo, MBA, CEO of Minnesota Gastroenterology, a GI practice based in St. Paul, and an expert in medical group management, assesses the pros and cons of implementing the PQRI system with host Dr. Mark DeLegge.

Guest: Mary Igo, MBA, RN Host: Mark DeLegge, MD The Physician Quality Reporting Initiative (PQRI) is a CMS-based program designed to help medical professionals measure performance outcomes in their practice. How does the PQRI define quality, and how can it provide more concrete measurements of quality? What do GI practices need to know when becoming involved in the PQRI? Mary Igo, MBA, CEO of Minnesota Gastroenterology, a GI practice based in St. Paul, and an expert in medical group management, assesses the pros and cons of implementing the PQRI system with host Dr. Mark DeLegge.

Evaluating Performance: The Physician Quality Reporting Initiative


Guest: Peter Cotton, MD     Host: Mark DeLegge, MD  The outcomes for endoscopy can vary greatly, depending on the training and technique of the endoscopist. Dr. Peter Cotton, professor of medicine at the Digestive Disease Center at the Medical University of South Carolina, discusses the risks of endoscopy, and quality-control measures, from the establishment of benchmarks to voluntary report cards to ensure quality outcomes. Dr. Mark DeLegge hosts.

Guest: Peter Cotton, MD Host: Mark DeLegge, MD The outcomes for endoscopy can vary greatly, depending on the training and technique of the endoscopist. Dr. Peter Cotton, professor of medicine at the Digestive Disease Center at the Medical University of South Carolina, discusses the risks of endoscopy, and quality-control measures, from the establishment of benchmarks to voluntary report cards to ensure quality outcomes. Dr. Mark DeLegge hosts.

Quality Outcomes for Endoscopy


Guest: Ronald Fogel, MD     Host: Jay Goldstein, MD  It's the third most commonly diagnosed cancer, with more than 150,000 new cases projected in 2008, and the second leading cancer killer at more than 50,000 deaths this year alone, yet questions remain about screening strategies for colorectal cancer. Given that many health insurance plans don't cover screenings, how can we find other avenues to address this dilemma? Dr. Ronald Fogel, chair of the Public Policy and Advocacy Committee of the AGA, probes vital issues with host Dr. Jay Goldstein.

Guest: Ronald Fogel, MD Host: Jay Goldstein, MD It's the third most commonly diagnosed cancer, with more than 150,000 new cases projected in 2008, and the second leading cancer killer at more than 50,000 deaths this year alone, yet questions remain about screening strategies for colorectal cancer. Given that many health insurance plans don't cover screenings, how can we find other avenues to address this dilemma? Dr. Ronald Fogel, chair of the Public Policy and Advocacy Committee of the AGA, probes vital issues with host Dr. Jay Goldstein.

Colorectal Cancer: Early Detection, Prevention and Treatment


Guest: Lawrence Kim, MD     Host: Mark DeLegge, MD           Endoscopy is extremely safe when performed by a qualified gastroenterologist. What role does accreditation play in ensuring patient safety? What's the difference between the associations that accredit ambulatory surgery centers? Host Dr. Mark DeLegge discusses what GIs need to know about accreditation with Dr. Lawrence Kim, a practicing gastroenterologist at South Denver Gastroenterology in Colorado.

Guest: Lawrence Kim, MD Host: Mark DeLegge, MD Endoscopy is extremely safe when performed by a qualified gastroenterologist. What role does accreditation play in ensuring patient safety? What's the difference between the associations that accredit ambulatory surgery centers? Host Dr. Mark DeLegge discusses what GIs need to know about accreditation with Dr. Lawrence Kim, a practicing gastroenterologist at South Denver Gastroenterology in Colorado.

Accreditation and Patient Safety in Endoscopy


Guest: William Chey, MD     Host: Mark DeLegge, MD     Guest: Nicholas Shaheen, MD, MPH  Gastrointestinal (GI) disease is a major source of morbidity and mortality, yet physicians and patients often regard it as a basic nuisance. What contributes to this perception, and how can we change it? Host Dr. Mark DeLegge welcomes two chairmen of the upcoming AGA Clinical Congress, Dr. William Chey, professor of internal medicine at the University of Michigan Medical School, and Dr. Nicholas Shaheen, associate professor of medicine at the University of North Carolina School of Medicine, to discuss strategies to help us and our patients keep current on GI disease.

Guest: William Chey, MD Host: Mark DeLegge, MD Guest: Nicholas Shaheen, MD, MPH Gastrointestinal (GI) disease is a major source of morbidity and mortality, yet physicians and patients often regard it as a basic nuisance. What contributes to this perception, and how can we change it? Host Dr. Mark DeLegge welcomes two chairmen of the upcoming AGA Clinical Congress, Dr. William Chey, professor of internal medicine at the University of Michigan Medical School, and Dr. Nicholas Shaheen, associate professor of medicine at the University of North Carolina School of Medicine, to discuss strategies to help us and our patients keep current on GI disease.

GI Disease: Practical Solutions for Improving Care


Guest: Lawrence Cohen, MD     Host: Mark DeLegge, MD           Propofol is used for deep sedation, and is often preferred by patients undergoing an endoscopy, since it's a short-acting agent. Can it be administered safely and effectively by trained gastroenterologists, or should an anesthesiologist be present to monitor the procedure? Dr. Larry Cohen, associate clinical professor at Mount Sinai School of Medicine, joins host Dr. Mark DeLegge to discuss the benefits, costs and risks of using propofol during endoscopy. From a medical-legal perspective, are gastroenterologists at more risk if they administer propofol during endoscopy than they would be if an anesthesiologist had been present?

Guest: Lawrence Cohen, MD Host: Mark DeLegge, MD Propofol is used for deep sedation, and is often preferred by patients undergoing an endoscopy, since it's a short-acting agent. Can it be administered safely and effectively by trained gastroenterologists, or should an anesthesiologist be present to monitor the procedure? Dr. Larry Cohen, associate clinical professor at Mount Sinai School of Medicine, joins host Dr. Mark DeLegge to discuss the benefits, costs and risks of using propofol during endoscopy. From a medical-legal perspective, are gastroenterologists at more risk if they administer propofol during endoscopy than they would be if an anesthesiologist had been present?

Endosocpy and Sedation with Propofol


Guest: David Peura, MD     Host: Jay Goldstein, MD  Helicobacter pylori, often known as H. pylori, was discovered in the 1980s and is found worldwide in the stomachs of billions of people. H. pylori can cause gastritis and ulcers, but often presents no symptoms or problems for years. How concerned should we be about the stomach bacterium? Host Dr. Jay Goldstein discusses with Dr. David Peura, professor of medicine at the University of Virginia School of Medicine, the extent to which H. pylori is still a health problem in the United States.

Guest: David Peura, MD Host: Jay Goldstein, MD Helicobacter pylori, often known as H. pylori, was discovered in the 1980s and is found worldwide in the stomachs of billions of people. H. pylori can cause gastritis and ulcers, but often presents no symptoms or problems for years. How concerned should we be about the stomach bacterium? Host Dr. Jay Goldstein discusses with Dr. David Peura, professor of medicine at the University of Virginia School of Medicine, the extent to which H. pylori is still a health problem in the United States.

Helicobacter Pylori: Still a Problem in the U.S?


Host: Jay Goldstein, MD     Guest: Stanley Cohen, MD  What types of small bowel abnormalities are most common among pediatric patients? How can physicians investigate suspected small bowel disease or gastrointestinal (GI) bleeding in our younger patients? Dr. Stanley Cohen, gastroenterologist at the Combined Center for Inflammatory Bowel Disease and Children's Center for Digestive Health Care at Children's Healthcare of Atlanta, and adjunct clinical professor of pediatrics, Emory University School of Medicine, in Atlanta, Georgia, discusses the roles of CT scans, MRIs and small bowel capsule endoscopy in evaluating pediatric patients with suspected small bowel disease. Dr. Jay Goldstein hosts.

Host: Jay Goldstein, MD Guest: Stanley Cohen, MD What types of small bowel abnormalities are most common among pediatric patients? How can physicians investigate suspected small bowel disease or gastrointestinal (GI) bleeding in our younger patients? Dr. Stanley Cohen, gastroenterologist at the Combined Center for Inflammatory Bowel Disease and Children's Center for Digestive Health Care at Children's Healthcare of Atlanta, and adjunct clinical professor of pediatrics, Emory University School of Medicine, in Atlanta, Georgia, discusses the roles of CT scans, MRIs and small bowel capsule endoscopy in evaluating pediatric patients with suspected small bowel disease. Dr. Jay Goldstein hosts.

Detecting Small Bowel Abnormalities in Pediatric Patients


Guest: Rebecca West, JD     Host: Mark DeLegge, MD  The cost of malpractice insurance and the cost of resolving malpractice claims continues to climb. What are the trends in premiums for gastroenterologists around the country? And what are some of the most common risks and most commonly alleged errors? What’s the likelihood of a gastroenterologist being sued during his career? Rebecca West, CEO of Piedmont Liability Trust, a non-profit serving the University of Virginia School of Medicine, joins host Dr. Mark DeLegge to discuss strategies for avoiding malpractice claims. Ms. West also provides an update on national efforts at tort reform and how malpractice insurance premiums might be affected.

Guest: Rebecca West, JD Host: Mark DeLegge, MD The cost of malpractice insurance and the cost of resolving malpractice claims continues to climb. What are the trends in premiums for gastroenterologists around the country? And what are some of the most common risks and most commonly alleged errors? What’s the likelihood of a gastroenterologist being sued during his career? Rebecca West, CEO of Piedmont Liability Trust, a non-profit serving the University of Virginia School of Medicine, joins host Dr. Mark DeLegge to discuss strategies for avoiding malpractice claims. Ms. West also provides an update on national efforts at tort reform and how malpractice insurance premiums might be affected.

Malpractice 101 for Gastroenterologists


Host: Jay Goldstein, MD     Guest: Jonathan Leighton, MD     Guest: Moshe Rubin, MD  Obscure gastrointesinal bleeding can pose investigational challenges. What are the potential causes of obscure GI bleeding? After initial negative upper endoscopy and colonoscopy tests are performed, what new technologies can help physicians more effectively detect small bowel abnormalities? Dr. Jonathan Leighton, professor of medicine and chair of the division of gastroenterology at the Mayo Clinic in Arizona, and Dr. Moshe Rubin, director of gastroenterology and program director of the GI fellowship training program at New York Hospital Queens Medical Center and the Weill-Cornell Medical College in New York, discuss the roles of small bowel capsule endoscopy, balloon-assisted enteroscopy, spiral enteroscopy, and CT enterography in evaluating patients with obscure GI bleeding. Dr. Jay Goldstein hosts.

Host: Jay Goldstein, MD Guest: Jonathan Leighton, MD Guest: Moshe Rubin, MD Obscure gastrointesinal bleeding can pose investigational challenges. What are the potential causes of obscure GI bleeding? After initial negative upper endoscopy and colonoscopy tests are performed, what new technologies can help physicians more effectively detect small bowel abnormalities? Dr. Jonathan Leighton, professor of medicine and chair of the division of gastroenterology at the Mayo Clinic in Arizona, and Dr. Moshe Rubin, director of gastroenterology and program director of the GI fellowship training program at New York Hospital Queens Medical Center and the Weill-Cornell Medical College in New York, discuss the roles of small bowel capsule endoscopy, balloon-assisted enteroscopy, spiral enteroscopy, and CT enterography in evaluating patients with obscure GI bleeding. Dr. Jay Goldstein hosts.

Evaluating Obscure GI Bleeding


The best podcasts on investing. For anyone interested in the stories in the investing industry, whether it's an interview with Ray Dalio or Ed Thorp to the writer of The Big Short. This topic includes the most fascinating stories from all the best investors. Add episodes you're interested into your queue below!

Best Investing Podcasts

The best philosophy podcast episodes. Asking questions about how to live a better life, what it means to be and do good, to the idea of God. This topic includes episodes that bring about important questions that everyone should be asking themselves. Add episodes you're interested into your queue below!